It's no secret that GLP-1 medications like Ozempic, Zepbound and Wegovy are helping people achieve amazing health and weight ...

Even a juggernaut like Eli Lilly ( LLY 2.71%) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering somewhat ...

SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...

Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide ...

It’s virtually impossible these days to read anything about type 2 diabetes without a mention of the new kind of medication called GLP-1 agonists—including Ozempic, Wegovy, and Zepbound. And for good ...

We recently compiled a list of the 10 Best Reddit Stocks To Buy Right Now. In this article, we are going to take a look at where Eli Lilly And Co.

NVO上个月要求FDA禁止仿药厂商生产复合司美格鲁肽，因为这些药物太复杂，无法安全复制。而目前的美国法规允许制药商通过改变药物成分来复制供应短缺的药物以满足需求。

Another issue for investors is that Eli Lilly adjusted its guidance for the year, now projecting its adjusted EPS to fall ...

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

Rather than bribing and wheedling physicians to pretty-please-prescribe-our-drug, websites allow companies to deal drugs ...

Novo Nordisk has today reported better-than-expected quarterly sales of its popular Wegovy weight-loss drug and narrowed its ...